Companies: 10,795·Total market cap: $144.5T
AngioDynamics, Inc.

AngioDynamics, Inc.

ANGONASDAQHealthcare● Active
$11.93
$-0.01(-0.08%)
Market Cap$492934477
P/E Ratio
52W High$13.99
52W Low$8.36

AngioDynamics, Inc. (ANGO) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

ango · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 11 Wall Street analysts in the past 3 months

SellBuy

Hold

11 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
5
Hold
6
Sell
0
Strong Sell
0
Total: 11 · Buy rate: 45.5%

12-Month Price Target

High

$22.00

Consensus

$16.50

+38.3% upside

Low

$12.00

Median: $16 · Last Close: $11.93

The AngioDynamics, Inc. (ANGO) analyst consensus is Hold, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month ANGO price target is $16.50, representing +38.3% upside from the current price of $11.93.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $17 (38.3%)

Consensus Target

$16.50

38.3% upside

High Target

$22

84.4%

Low Target

$12

0.6%

Current Price

$11.93

as of today

Based on analyst price targets, the ANGO stock price prediction for the next 12 months ranges from $12 to $22. The consensus ANGO price forecast of $16.50 implies 38.3% upside from the current price of $11.93.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$12.051.02%

1-day model range: $12–$12.1. Peak: $12.1 (+1.02%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$12-1.3%
2028$12-2.1%
2029$12-2.5%
2030$12-2.7%
2031-2.8%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)63.3Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · ANGO · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$11.62BUY
MA 10$11.59BUY
MA 20$11.42BUY
MA 50$11.02BUY
MA 100$10.91BUY
MA 200$11.32BUY
Current $ANGO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$11.74BUY
EMA 10$11.62BUY
EMA 20$11.47BUY
EMA 50$11.21BUY
EMA 100$11.14BUY
EMA 200$10.95BUY
Current $ANGO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Canaccord Genuity2026-04-06
Maintains
BuyBuy
Canaccord Genuity2025-10-03
Maintains
BuyBuy
Canaccord Genuity2025-07-16
Maintains
BuyBuy
HC Wainwright & Co.2025-07-16
Maintains
BuyBuy
HC Wainwright & Co.2025-04-07
Maintains
BuyBuy
HC Wainwright & Co.2025-01-10
Maintains
BuyBuy
Canaccord Genuity2025-01-09
Maintains
BuyBuy
HC Wainwright & Co.2024-12-10
Maintains
BuyBuy
Canaccord Genuity2024-10-04
Maintains
BuyBuy
HC Wainwright & Co.2024-10-04
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on AngioDynamics, Inc. (ANGO) stock. Of the recent 56 rating actions, 6 were upgrades and 6 were downgrades. 11 analysts currently cover ANGO.

Analyst Recommendation Trends

Buy ratings11
Hold ratings00
Sell ratings00

ANGO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$314M

↓ 9.9% YoY

Revenue Next Year

$330M

↑ 4.9% YoY

EPS This Year

$-0.16

EPS Next Year

$-0.16

↓ 3.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ANGO EPS of $-0.16 for the current fiscal year, based on estimates from 3 analysts. The ANGO revenue forecast is $314M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ANGO stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ANGO price target is $16.50 (+38.3% upside), with an analyst consensus of Hold.

The ANGO short-term stock prediction for tomorrow is $12.05 (+1.02%). The ANGO stock price prediction for 2027 estimates an average of $12. The ANGO stock prediction for 2030 projects a range of $11–$12.

AngioDynamics, Inc. trades on NASDAQ under the ticker ANGO. The ANGO stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 45% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ANGO forecast · 8 questions

According to 11 Wall Street analysts, the average 12-month ANGO price target is $16.50, with a high forecast of $22.00 and a low of $12.00. The median price target is shown in the chart above when available. This implies +38.3% potential upside from the current price of $11.93.

ANGO price targetWhat is ANGO price targetANGO analyst price targetANGO 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.